News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syneron Medical Ltd. (ELOS) Announces International Launch of the ePlus(TM) Complete Aesthetic Work Station


6/6/2012 11:38:58 AM

YOKNEAM, Israel, June 6, 2012 /PRNewswire/ --


Upgradeable State of the Art Platform System Features a Full Range of the Most In-Demand Applications

Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today the International launch of the ePlus Complete Aesthetic Work Station. The ePlus system will be launched at the 9th Spring Symposium of the European Academy of Dermatology and Venereology (EADV) meeting, June 6-10, 2012 in Verona, Italy. The ePlus system has received CE Mark approval from the European Union and is available in European and Asian markets.

(Logo: http://photos.prnewswire.com/prnh/20120528/535447 )
(Photo: http://photos.prnewswire.com/prnh/20120606/535447 )

The ePlus system utilizes Syneron's proprietary els combination of optical energy and bi-polar radio frequency (RF) with 10 different treatment applicators for a wide and expanding range of clinical indications. It features an intuitive touch screen user interface that incorporates full guided treatment modes for all 10 applicators and allows for simultaneous connection of up to 3 applicators. The ePlus system includes the full facial rejuvenation functionality of the recently launched eTwo tabletop system, including eTwo's Sublime and Sublative applications and new Sublative iD treatment tips, which maximize treatment options and results. ePlus also supports Syneron's recently introduced Motif Modes of operation, providing fast, effective and virtually pain-free hair removal and skin treatments. The proprietary Active Dermal Monitoring feature which monitors the skin's impedance changes throughout the treatment, as well as the Intelligent Feedback System (IFS) and integrated sapphire contact cooling ensure a strong safety profile for all applications.

Louis P. Scafuri, Chief Executive Officer of Syneron Medical, said, "The ePlus system is an exciting new offering that incorporates the treatment capabilities and functionality of several of our most popular els-based systems into a single, upgradeable work station. Its intuitive touch screen interface is designed to enhance workflow and clinical outcomes by guiding practitioners through each of the system's treatment options. It is also designed to enhance the patient experience with features such as the Motif Mode for pain-free treatments. We believe the ePlus system will be well received in its international launch, particularly as customers look to maximize their facility and capital investments with our advanced and versatile system that can grow with their practice."

About the EADV

Founded in 1987, EADV is a non-profit association whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases.

About Syneron Medical Ltd.

Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Contacts:

Asaf Alperovitz, Chief Financial Officer
+972-73-244-2283
Email: asafa@syneron.com

Zack Kubow, The Ruth Group
+1-646-536-7020
Email: zkubow@theruthgroup.com

SOURCE Syneron Medical Ltd


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES